Results 1 to 10 of about 120,903,364 (211)

A Proton Nuclear Magnetic Resonance-Based Metabonomics Study of Metabolic Profiling in Immunoglobulin a Nephropathy

Clinics, 2012
OBJECTIVES: Immunoglobulin A nephropathy is the most common cause of chronic renal failure among primary glomerulonephritis patients. The ability to diagnose immunoglobulin A nephropathy remains poor.
Songbai Liao, Yong Dai
exaly   +4 more sources

B-cell modulators in immunoglobulin A nephropathy. [PDF]

Front Immunol
Immunoglobulin A nephropathy (IgAN), defined by mesangial immune-complex deposition enriched for galactose-deficient IgA1 (Gd-IgA1), is the most prevalent biopsy-confirmed primary glomerulonephritis worldwide.
Rajasekaran A, Novak J, Rizk DV.
europepmc   +2 more sources

Preliminary real-world efficacy and safety of telitacicept in pediatric immunoglobulin A nephropathy: An exploratory retrospective case series [PDF]

J Int Med Res
Immunoglobulin A nephropathy is a predominant cause of chronic kidney disease in the pediatric population. Despite standard-of-care treatments, a significant subset of children remains refractory to conventional immunosuppressive therapies, necessitating
Yun Wang, Ying Zhu, Haitao Wang, Fang Deng   +3 more
europepmc   +2 more sources

A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy

Frontiers in Cellular and Infection Microbiology, 2020
The pathogenesis of immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) is characterized by immune dysregulation, which is related to gut dysbiosis.
Shiren Sun, Xiaoxuan Ning, Di Wang
exaly   +3 more sources

Reduction in proteinuria after immunosuppressive therapy and long-term kidney outcomes in patients with immunoglobulin A nephropathy [PDF]

The Korean Journal of Internal Medicine, 2021
Background/Aims Despite controversy regarding the benefits of immunosuppressive therapy in immunoglobulin A nephropathy (IgAN), clinical outcomes may vary depending on the patient’s responsiveness to this therapy.
Shin Chan Kang, Hyung Woo Kim, Tae Ik Chang, Ea Wha Kang, Beom Jin Lim, Jung Tak Park, Tae-Hyun Yoo, Hyeon Joo Jeong, Shin-Wook Kang, Seung Hyeok Han   +9 more
doaj   +1 more source

Role of the intestinal MALT in pathogenesis of the IgA-nephropathy

Терапевтический архив, 2021
Modern view on pathogenesis of immunoglobulin (Ig)A-nephropathy and possible relation to intestinal MALT-system activity is presented in the article. Aberrant glycosylation of IgA and increased association of IgA-nephropathy with intestinal diseases or ...
Sergei V. Guliaev, Leonid A. Strizhakov, Natalia V. Chebotareva, Sergei V. Moiseev   +3 more
doaj   +1 more source

Possible Link between IgA Nephropathy and B-cell Acute Lymphoblastic Leukemia

Turkish Journal of Nephrology, 2020
IgA nephropathy (IgA-N) is the most common glomerulonephritis type globally. IgA-N is usually accepted as a kidney disease; however, IgA-N has been reported with infections, autoimmune diseases, and malignancies in the literature.
Eray Eroğlu, Uğur Türkmen, İsmail Koçyiğit, Hülya Akgün, Sümeyra Koyuncu, Murat Hayri Sipahioğlu, Bülent Tokgöz, Oktay Oymak   +7 more
doaj   +1 more source

Hyperuricemia as a marker for progression of immunoglobulin A nephropathy

Kidney Research and Clinical Practice, 2012
Background: The variable clinical and histopathological manifestations of immunoglobulin A nephropathy (IgAN) make it difficult to predict disease progression.
Su-Ji Kim, Jung-Hoon Kim, Hyo-Wook Gil, Jong-Oh Yang, Eun-Young Lee, Sae-Yong Hong   +5 more
doaj   +1 more source

Gross hematuria can be an impact of severe acute respiratory syndrome coronavirus 2 vaccination on immunoglobulin A nephropathy: a case report

Journal of Medical Case Reports, 2022
Background Immunoglobulin A nephropathy is typically accelerated by upper respiratory tract infections and can relapse following vaccination. There have been reports of patients who presented with immunoglobulin A nephropathy flares with or without gross
Hiroshi Kanamori
doaj   +1 more source

Association between the progression of immunoglobulin A nephropathy and a controlled status of hypertension in the first year after diagnosis [PDF]

The Korean Journal of Internal Medicine, 2022
Background/Aims Hypertension is considered a risk factor in immunoglobulin A nephropathy (IgAN). However, after IgAN diagnosis, the relationship between early blood pressure control and renal prognosis remains unclear.
Tae Ryom Oh, Hong Sang Choi, Se Won Oh, Jieun Oh, Dong Won Lee, Chang Seong Kim, Seong Kwon Ma, Soo Wan Kim, Eun Hui Bae, on behalf of the Korean GlomeruloNEphritis sTudy (KoGNET) Group   +9 more
doaj   +1 more source